Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 13, 2024Journal of Medical EconomicsOpen Access

Longitudinal characterization of symptoms, healthcare resource utilization, and costs among people with thrombotic thrombocytopenic purpura compared with non-thrombotic thrombocytopenic purpura controls

View Full Paper
Ask AI
Bookmark
Share

Authors

SXShan XingGuangzhou University of Chinese MedicineMBMichael BullanoTakeda (United States)SHSarah HaleAmyotrophic Lateral Sclerosis Therapy Development Institute

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xing et al. (2024) studied this question.

synapsesocial.com/papers/68e5c859b6db64358755ef9fhttps://doi.org/10.1080/13696998.2024.2391663
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevalence of neuropsychiatric symptoms and stroke in patients with hereditary thrombotic thrombocytopenic purpura2022 · 14 citations
  2. 2Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management2021 · 237 citations
  3. 3Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group2020 · 177 citations
  4. 4Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship2023 · 17 citations
  5. 5Characterization and treatment of congenital thrombotic thrombocytopenic purpura2019 · 182 citations